Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory L. Cowan currently holds 90,055 shares of RVL Pharmaceuticals plc (RVLP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory L. Cowan has been a net neutral trader of RVLP stock. They have purchased $0 and sold $0 worth of shares.
Gregory L. Cowan's most recent insider trade was on Jul 5, 2023, when they sold 40,000 shares at $0.00 per share.
Gregory L. Cowan serves as Executive at RVL Pharmaceuticals plc (RVLP). They have executed 11 insider transactions totaling $0 over their tenure at the company.
Gregory L. Cowan holds the position of Executive at RVL Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Gregory L. Cowan has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gregory L. Cowan was on Nov 21, 2017, when they sold $260.2K worth of VWR shares. This transaction involved 7,827 shares at $33.25 per share.
Gregory L. Cowan currently owns 90,055 shares of RVL Pharmaceuticals plc (RVLP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory L. Cowan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory L. Cowan has 11 Form 4 filings on record as an insider at RVL Pharmaceuticals plc.
Set alerts for Gregory L. Cowan and 40,000+ other insiders.